Safety of intermediate dose of low molecular weight heparin in COVID-19 patients.
Mattioli M, Benfaremo D, Mancini M, Mucci L, Mainquà P, Polenta A, Baldini PM, Fulgenzi F, Dennetta D, Bedetta S, Gasperoni L, Caraffa A, Frausini G.
Mattioli M, et al. Among authors: fulgenzi f.
J Thromb Thrombolysis. 2021 Feb;51(2):286-292. doi: 10.1007/s11239-020-02243-z.
J Thromb Thrombolysis. 2021.
PMID: 32794132
Free PMC article.